ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,930.85
1.09%
US Tech 100
20,836.00
1.31%
Dow Jones
42,840.26
1.18%
Brent Oil
72.72
0.00%
Bitcoin
97,292.25
-0.48%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Aspira Womans Health Inc (AWH) Quote

Aspira Womans Health Inc

Aspira Womans Health Inc (AWH)

NASDAQ
0.77
-0.0075
(-0.96%)
Closed December 21 4:00PM
Delayed by 15 minutes
0.8085
0.0385
(5.00%)
After Hours: 7:05PM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
0.8085
Bid
0.7403
Ask
0.97
Volume
44,591
0.7201 Day's Range 0.792
0.6679 52 Week Range 5.65
Market Cap
13.475M
Previous Close
0.7775
Open
0.744101
Last Trade
100
@
0.8085
(formt)
Last Trade Time
Financial Volume
$ 33,440
VWAP
0.749932
Average Volume (3m)
95,231
Shares Outstanding
16,667,255
Dividend Yield
-
PE Ratio
-3.99
Earnings Per Share (EPS)
-1
Revenue
9.15M
Net Profit
-16.69M

About Aspira Womans Health Inc

Aspira Womens Health Inc is transforming women's health with the discovery, development, and commercialization of testing options and bio-analytical solutions that help physicians assess risk, optimize patient management and improve gynecologic health outcomes for women. OVA1 plus combines its FDA-c... Aspira Womens Health Inc is transforming women's health with the discovery, development, and commercialization of testing options and bio-analytical solutions that help physicians assess risk, optimize patient management and improve gynecologic health outcomes for women. OVA1 plus combines its FDA-cleared products OVA1 and OVERA to detect the risk of ovarian malignancy in women with adnexal masses. Aspira GenetiX testing offers both targeted and more comprehensive genetic testing options with a gynecologic focus. Its focus is on delivering products that allow healthcare providers to stratify risk, facilitate early detection, and optimize treatment. Show more

Sector
In Vitro,in Vivo Diagnostics
Industry
In Vitro,in Vivo Diagnostics
Website
aspirawh.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Aspira Womans Health Inc is listed in the In Vitro,in Vivo Diagnostics sector of the NASDAQ with ticker AWH. The last closing price for Aspira Womans Health was $0.78. Over the last year, Aspira Womans Health shares have traded in a share price range of $ 0.6679 to $ 5.65.

Aspira Womans Health currently has 16,667,255 shares outstanding. The market capitalization of Aspira Womans Health is $12.96 million. Aspira Womans Health has a price to earnings ratio (PE ratio) of -3.99.

Ask ADVFN Intelligence (AI)

AWH Latest News

More News

Form 8-K - Current report

December 16 2024
Edgar (US Regulatory)

Aspira Women’s Health Announces Appointment of Dr. Sandra Milligan as Interim CEO

AUSTIN, Texas, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira” or the “Company”) (NASDAQ: AWH), a bio-analytical based women’s health company focused on the development of...

December 16 2024
GlobeNewswire Inc.

Aspira Women’s Health Successfully Reaches the First Milestone of the ARPA-H $10 Million Award

AUSTIN, Texas, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira”) (NASDAQ: AWH), a bio-analytical based women’s health company focused on the development of gynecologic...

December 03 2024
GlobeNewswire Inc.

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

November 22 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

November 19 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

November 14 2024
Edgar (US Regulatory)

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

November 14 2024
Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

November 14 2024
Edgar (US Regulatory)

Form 8-K - Current report

November 14 2024
Edgar (US Regulatory)

Aspira Women’s Health Reports Selected Third Quarter 2024 Financial Results

Q3 2024 OvaSuiteSM revenue of $2.3 million and volume of 6,001 units Cash utilization for the third quarter was $2.9 million, a decrease of 12% compared to the second quarter of 2024 Full year...

November 14 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.137520.49180327870.6710.850.671901270.76222632CS
40.088512.29166666670.720.8990.6694810720.78185093CS
12-0.0015-0.1851851851850.811.380.6679952310.86409288CS
26-0.8015-49.78260869571.611.81240.66791092271.04953432CS
52-1.7915-68.90384615382.65.650.6679756801.64633137CS
156-26.0415-96.988826815626.8529.70.66792703659.79481146CS
260-61.2915-98.698067632962.1158.10.667944665742.65114507CS

AWH - Frequently Asked Questions (FAQ)

What is the current Aspira Womans Health share price?
The current share price of Aspira Womans Health is $ 0.8085
How many Aspira Womans Health shares are in issue?
Aspira Womans Health has 16,667,255 shares in issue
What is the market cap of Aspira Womans Health?
The market capitalisation of Aspira Womans Health is USD 12.96M
What is the 1 year trading range for Aspira Womans Health share price?
Aspira Womans Health has traded in the range of $ 0.6679 to $ 5.65 during the past year
What is the PE ratio of Aspira Womans Health?
The price to earnings ratio of Aspira Womans Health is -3.99
What is the cash to sales ratio of Aspira Womans Health?
The cash to sales ratio of Aspira Womans Health is 7.28
What is the reporting currency for Aspira Womans Health?
Aspira Womans Health reports financial results in USD
What is the latest annual turnover for Aspira Womans Health?
The latest annual turnover of Aspira Womans Health is USD 9.15M
What is the latest annual profit for Aspira Womans Health?
The latest annual profit of Aspira Womans Health is USD -16.69M
What is the registered address of Aspira Womans Health?
The registered address for Aspira Womans Health is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Aspira Womans Health website address?
The website address for Aspira Womans Health is aspirawh.com
Which industry sector does Aspira Womans Health operate in?
Aspira Womans Health operates in the IN VITRO,IN VIVO DIAGNOSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MYSZMy Size Inc
$ 4.2001
(211.12%)
120.01M
NVNINVNI Group Ltd
$ 8.26
(209.36%)
76.64M
TPICTPI Composites Inc
$ 2.45
(100.82%)
33.95M
ICGIntchains Group Ltd
$ 8.77
(88.60%)
527.61k
HSDTHelius Medical Technologies Inc
$ 0.884851
(84.34%)
120.4M
CYNCYNGN Inc
$ 0.4603
(-71.41%)
27.91M
MTEMMolecular Templates Inc
$ 0.1502
(-57.09%)
8.75M
PRFXPainReform Ltd
$ 5.15
(-53.85%)
2.94M
GALTGalectin Therapeutics Inc
$ 1.03
(-48.50%)
9.27M
BCABBioAtla Inc
$ 0.6923
(-41.82%)
6.25M
EDBLEdible Garden AG Inc
$ 0.24
(65.06%)
354.32M
APTOAptose Biosciences Inc
$ 0.28
(64.51%)
305.1M
TNXPTonix Pharmaceuticals Holding Corporation
$ 0.606999
(6.49%)
292.16M
NVDANVIDIA Corporation
$ 134.70
(3.08%)
287.21M
PLTRPalantir Technologies Inc
$ 80.55
(8.54%)
277.63M

AWH Discussion

View Posts
ed3/6me ed3/6me 3 months ago
As they seem to have a problem with profit ..I agree
👍️0
tonyjh tonyjh 3 months ago
Never mind. This company is a short sellers wet dream. Just wait for the RS and go short. Easy money.
👍️0
tonyjh tonyjh 3 months ago
As a new investor, I would. They have endometriosis data for an endometriosis test for which the 2 year study concluded in July due out this month I believe. 15 million or so shares. I’ve got an average of about $15 for what it’s worth lol
👍️0
ed3/6me ed3/6me 4 months ago
Is this worth investing in what seems to be a death spiral?
👍️0
Monksdream Monksdream 6 months ago
AWH new 52 week low

👍️0
Monksdream Monksdream 6 months ago
AWH new 52 week low
👍️0
Awl416 Awl416 1 year ago
Impressive month
👍️0
tonyjh tonyjh 1 year ago
Let’s go, boys. Pump this fkr and let me out.
👍️0
AJ Freely AJ Freely 1 year ago
$AWH- Loads of insider Buying
Private investor buys 38% of the company shares
Up 5.4% Pre-Market/ Current Price $2.58
👍️0
Profit Profit 1 year ago
CEO Nichole picks up 12,000 shares at $3.98 a lot of insider buys with this financing Very Bullish
👍️0
AJ Freely AJ Freely 1 year ago
$AWH - Up 6% Pre-Market/ Current Price $2.68
Entered into a securities purchase agreement for 1,694,820 shares for $4.7 million
Insider buys for about 14,000 shares
👍️0
Profit Profit 2 years ago
Ready to Run Lets Go!
👍️0
MWM MWM 4 years ago
$AWH Nice, I took my eyes off this one!

👍️0
paps3 paps3 4 years ago
AWH 7.79 News https://thefly.com/landingPageNews.php?id=3236501&headline=AWH-Cantor-Fitzgerald-starts-Aspira-Womens-Health-at-Overweight-with--target
👍️0
Hypi Hypi 4 years ago
Love the chart as we bottomed, consolidated and now accumulation is underway along with a possible short squeeze.

3 great presentations by the CEO at various investor events over the last month. Partnership with ABBV for Endometriosis testing ($1.2B-$4B market) along with OVA1 tests back at pre-Covid levels, more insurers coming on board like Anthem who controls 21 BC/BS throughout the US.

Making great strides on replacing CA-125 with OVA1 as the SOC which would result in $1B in annual sales.

By 2023 you could be looking at a multi-billion annual revenue stream for AWH.

10 million shares short and float is very small as most shares tied up with insiders and other investors who aren't selling. Going to be a fun run into year end and then the smoke show begins in 2021.

New 52 week highs coming around the corner.
👍️0
Hypi Hypi 4 years ago
Yea that's what caused the big pop in price and volume surge. Unfortunately, we didn't hold the gains this week and we will see what comes of an actual deal?
👍️0
tonyjh tonyjh 4 years ago
MYOV spoke about AWH?
👍️0
Hypi Hypi 4 years ago
Deal with MYOV and ABBV forthcoming for Endometriosis. MYOV spoke about it today on a call with their new drug. We also know CEO of AWH has stated they are in talks with ABBV for the same test. Might explain the volume and price action today? Good time to buy in before this one moon shots. JMO
👍️0
berdboy berdboy 4 years ago
SO GLAD I SOLD BEFORE FILINGS.. HAD A FEELING AWH
👍️0
TAFAZI69 TAFAZI69 4 years ago
The new week... will be fondamental
👍️0
Hypi Hypi 4 years ago
Very excited about the upcoming week and earnings conference call.
We are finally the SOC for Ovarian Cancer Testing and growth has now take off with numbers exceeding 50% quarter over quarter. If Covid-19 didn't hit this stock would already be at $10 a share as testing slowed down, but is starting to regain momentum. 2nd half will be phenomenal.

We will hear about new branding and overall company strategy and a lot more like the following updates:

We could/should hear about new insurance coverage which is key as we added Cigna and Medicare in the 1st quarter opening us up to 160 million possible patients. More insurers to follow.

We could/should hear about new networks of clinics with vast #'s of physicians now using OVA1 for all their Ovarian cancer testing.

We could/should get an update on other partnerships along with Endometriosis progess with possible BP partner.

The sky is the limit and so is the stock price.








👍️0
MWM MWM 4 years ago
Sounds good!
👍️0
Hypi Hypi 4 years ago
AWH have several key catalysts that will drive this stock to new 52 week highs and they should be all around upcoming earnings call in early-mid August.

1.) Announcement of a major doctor network (up to 3500) that will be utilizing OVA1 in their practices and as the SOC for testing Ovarian cancer.

2.) Announcement of a partnership with a major player (possibly Abbvie) for endometriosis test and other collaborations.

3,) Earnings call with forward guidance showing substantial growth.

Big accumulation of stock over last several months and now a nice consolidation pattern in that $3.75-$4.50 range. We should break out shortly (next two weeks) and obviously any of the above news events will be a catalyst to take us to new highs.

This company will be bought out by Quest Diagnostics, Roche or some other large entity in the healthcare space now that insurance is in place.
👍️0
MWM MWM 4 years ago
Not seeing any reason for this pullback, might be a buying opportunity...


👍️0
TAFAZI69 TAFAZI69 4 years ago
10 dollar
👍️0
MWM MWM 4 years ago
I'm waiting to see a new 13D or G filing...

https://fintel.io/so/us/vrml
👍️0
budgetthis budgetthis 4 years ago
Loving this AWH the last few days, MWM.......!

Very solid trading, indeed !

$$ AWH $$
👍️0
MWM MWM 4 years ago
$AWH What a Beast!

👍️0
MWM MWM 4 years ago
AWH Still heading higher!

👍️0
MWM MWM 4 years ago
Looking strong again!

👍️0
MWM MWM 4 years ago
AWH after a nice consolidation looks ready to continue!

👍️0
MWM MWM 4 years ago
AWH might be ready again...


👍️0
TAFAZI69 TAFAZI69 5 years ago
10 dollar and if at august ..good news ...20
👍️0
MWM MWM 5 years ago
Waiting for the Momo to Return. Hack of a move but I think we head much higher!

👍️0
TAFAZI69 TAFAZI69 5 years ago
We start trading tomorrow with the new ticker.... in Europe
We hope for 7
👍️0
TrendTrade2016 TrendTrade2016 5 years ago
VRML everyone came late, I was screaming since 2.50!
👍️0
MWM MWM 5 years ago
$VRML $AWH so did all the insiders buy the warrants? If they did then that is a STRONG showing of Confidence! WOW!
👍️0
MWM MWM 5 years ago
$VRML closing well! Looking forward to the Name change and new symbol tomorrow!

$AWH
👍️0
DTGoody DTGoody 5 years ago
That would be awesome!
👍️0
DTGoody DTGoody 5 years ago
I agree, I added some $5 calls for June as well. At .20 cents these are cheap! I think this catches a major bid once the name and symbol change takes place on June 12th. I believe todays prices are a gift. Good Luck to all of us here!
👍️0
MWM MWM 5 years ago
I think it could easily bounce right back up. Fingers crossed!
👍️0
budgetthis budgetthis 5 years ago
Maybe tomorrow, with the new symbol ........ we can hope !!
👍️0
budgetthis budgetthis 5 years ago
I agree, DT !! Nice grab on your options !!

I got a few more June 19th, $5.00 calls today for cheap......we’re looking really good here, imho......the crazy overall market is giving us a nice loading opportunity.......lol.
👍️0
MWM MWM 5 years ago
I'll take some more news of massive OVA1 adoption!
👍️0
DTGoody DTGoody 5 years ago
Yes!!! They will have to cover! This is going to be a lot of fun soon!!
👍️0
budgetthis budgetthis 5 years ago
Looking forward to our symbol change and the required covering of all outstanding short shares in the process......!

$$ VRML $$
👍️0
MWM MWM 5 years ago
Damn, yes you did!
👍️0
DTGoody DTGoody 5 years ago
I Bought some January $5 calls for $1.05! I stole those!
👍️0
TAFAZI69 TAFAZI69 5 years ago
TIME TO BUY
👍️0
TAFAZI69 TAFAZI69 5 years ago
Load all.you can
👍️0

Your Recent History

NASDAQ
AWH
Aspira Womans Health
AMEX
MGK
Vanguard Mega Cap Growth...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads